Starting March 18, 2026, Washington state became the first place in the country to fully cover an AI companion robot through Medicaid. The device is ElliQ, a tabletop assistant made by Intuition Robotics, and it is now available at no cost to eligible recipients enrolled in the state’s Community First Choice and Roads to Community Living long-term care programs — people receiving services in their own homes rather than in institutions.
A First for Social Robots in American Healthcare
Washington’s Health Care Authority authorized a statewide reimbursement billing code specifically for ElliQ, categorizing it as a “Smart Care Device.” That distinction matters: Medicaid programs have covered medical hardware like hospital beds and wheelchairs for decades, but a conversational AI companion has never before had its own dedicated reimbursement pathway. Beneficiaries who qualify get the device fully covered, with no billing information collected from them directly.
What ElliQ Actually Does All Day
ElliQ was designed by Intuition Robotics, founded by Dor Skuler, as a proactive conversational companion rather than a passive assistant that waits to be asked something. It initiates daily check-ins, prompts medication reminders, offers cognitive and physical wellness exercises, and connects users to family members and outside services. It doesn’t have a humanoid body or mobility; it sits on a tabletop and communicates through voice, light and a small screen, aimed specifically at older adults living alone.
The Loneliness Numbers That Justify the Bet
The policy push traces back to a well-documented problem: roughly one-third of adults ages 50 to 80 report feeling lonely or isolated, according to survey data cited by researchers studying elder care technology, and social isolation has been linked to a 35% higher risk of death from any cause among older adults. States have been experimenting with ElliQ informally for years — New York’s Office for the Aging distributed thousands of units starting in 2022 — but Washington’s move creates the first ongoing, structural Medicaid reimbursement mechanism rather than a one-time grant-funded pilot.
Believers and Doubters
Advocates for the program argue that a $1,000-$1,500 tabletop device is a bargain compared to the cost of assisted living placement or emergency response after an unwitnessed fall, and that daily engagement from a device that never gets tired of chatting can meaningfully extend the time someone can safely stay in their own home. Critics, including some gerontologists and disability advocates, counter that a robot is a poor substitute for human contact and worry that Medicaid dollars earmarked for in-home care could be redirected toward technology instead of paying for more hours of human caregivers, who are already in chronically short supply nationwide. Some also flag that data privacy protections for conversations recorded by an always-listening companion device in a Medicaid beneficiary’s home haven’t been fully tested in court.
The Regulatory Path Nobody Else Has Taken Yet
What sets Washington apart isn’t the robot itself but the reimbursement code. Most home-care technology reaches seniors either through private purchase, a nonprofit grant, or a bundled managed-care contract. A standalone statewide Medicaid billing code specifically for a companion AI product creates a template other states can copy without having to build a business case from scratch. Aging-services agencies in several other states have said they are watching Washington’s rollout closely before deciding whether to pursue similar reimbursement authorizations of their own.
What Comes Next
The real test will be utilization and outcomes data: how many eligible beneficiaries actually enroll, whether it measurably reduces emergency calls or delays a move to assisted living, and whether Washington sees savings large enough to justify expanding eligibility beyond the two current program tracks. Intuition Robotics, for its part, is likely to use Washington as the proof point it needs to pitch other state Medicaid programs and, eventually, federal Medicare Advantage plans, on covering ElliQ and devices like it as a standard part of home-based long-term care rather than a novelty add-on.
Photo: tookapic / PIXABAY via Pixabay
